XML 52 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Revision of Prior Period Financial Statements
12 Months Ended
Dec. 31, 2020
Accounting Changes and Error Corrections [Abstract]  
Revision of Prior Period Financial Statements

23. Revision of Prior Period Financial Statements

 

During the audit for the year ended December 31, 2020 an error was discovered relating to share issuances resulting from an anti-dilution agreement. The share issuances for the three months ended March 31, 2020 were 2,000,000 and 458,834 shares of common stock respectively. The anti-dilution agreement relating to a 2017 share subscription payable agreement was triggered in March 2019 upon the Company’s stock split. Please refer to note 9.

 

We revised certain prior period financial statements for an immaterial error related to the recognition of the deemed dividend related to

 

down-round features along with the associated shares issuance and professional fees (Note 1). A summary of revisions to our previously reported financial statements presented herein for comparative purposes.

 

The cumulative effect of the adjustments on all prior periods to Stockholders’ Equity as of June 30, 2019, September 30, 2019, December 30, 2019 and March 31, 2020 reflected below:

 

    Common Stock     Additional Paid-in     Share Subscriptions     Share Subscription     Accumulated     Cumulative translation    

Total

Stockholders’ Equity

 
    Shares     Amount      Capital      Receivable     Payable     Deficit     adjustment     (Deficit)  
Balance at June 30, 2019     28,177,966     $ 2,817     $ 8,309,293     $ (1,577 )   $ 1,853,819     $ (10,482,521 )   $ (23,624 )   $ (341,792 )
Revision     12,719,566     $ 1,273     $ 182,509       -     $ 781,298     $ (965,079 )     -       -  
Balance at June 30, 2019, as revised     40,897,532     $ 4,090     $ 8,491,802     $ (1,577 )   $ 2,635,117     $ (11,447,600 )   $ (23,624 )   $ (341,792 )
                                                                 
Balance at September, 2019     38,506,721     $ 3,850     $ 8,230,982     $ (1,577 )   $ 1,606,097     $ (10,212,150 )   $ (46,116 )   $ (418,915 )
Revision     1,400,069     $ 141     $ 183,641       -     $ 781,298     $ (965,079 )     -       -  
Balance at September 30, 2019, as revised     39,906,790     $ 3,991     $ 8,414,623     $ (1,577 )   $ 2,387,395     $ (11,177,230 )   $ (46,116 )   $ (418,915 )
                                                                 
Balance at December 31, 2019     41,906,790     $ 4,191     $ 8,381,231     $ (1,577 )   $ 1,511,080     $ (10,768,906 )   $ (8,580 )   $ (882,561 )
Revision     -       -     $ 261,192       -     $ 648,315     $ (909,507 )     -       -  
Balance at December 31, 2019, as revised     41,906,790     $ 4,191     $ 8,642,423     $ (1,577 )   $ 2,159,395     $ (11,678,413 )   $ (8,580 )   $ (882,561 )
                              -                                  
Balance at March 31, 2020     46,547,749     $ 4,655     $ 9,060,739     $ (1,577 )   $ 1,178,608     $ (10,961,172 )   $ (8,580 )   $ (727,327 )
Revision     2,458,834     $ 246     $ 731,946       -     $ 137,315     $ (869,507 )     -       -  
Balance at March 31, 2020, as revised     49,006,583     $ 4,901     $ 9,792,685     $ (1,577 )   $ 1,315,923     $ (11,830,679 )   $ (8,580 )   $ (727,327 )

 

The Consolidated Statements of Operations and Comprehensive Loss has been revised to reflect the correction for the year ended December 31, 2019 and three months ended March 31, 2020 as follows:

 

    For the Year Ended December 31, 2019  
    As previously reported     Revision     As Revised  
Professional Fees   $ 570,852     $ (55,573 )   $ 515,279  
Total Operating Expenses   $ 831,971     $ (55,573 )   $ 776,398  
Loss from Operations   $ (593,424 )   $ (55,573 )   $ (537,851 )
Net Loss   $ (414,607 )   $ (55,573 )   $ (359,034 )
Comprehensive Loss   $ (419,574 )   $ (55,573 )   $ (364,001 )
Loss per Share–Basic and Diluted   $ (0.01 )     -     $ (0.01 )

 

    For the Three Months Ended March 31, 2020  
    As previously reported     Revision     As Revised  
Professional Fees   $ 149,465     $ (40,000 )   $ 109,465  
Total Operating Expenses   $ 178,471     $ (40,000 )   $ 138,471  
Loss from Operations   $ (164,455 )   $ 40,000     $ (124,455 )
Net Loss   $ (192,266 )   $ 40,000     $ (152,266 )
Comprehensive Loss   $ (192,266 )   $ 40,000     $ (152,266 )
Loss per Share–Basic and Diluted   $ (0.00 )     -     $ (0.00 )